Merck’s Acquisition of EyeBio Finalized

Merck (NYSE:MRK) is trending on Friday. The company announced the acquisition of EyeBio, introducing a novel candidate to Merk’s pipeline, Restoret. What To Know: Restoret has shown promising results in a Phase 1b/2a AMARONE study in participants with diabetic macular…

Money
Jul 12, 2024
Why Materials Stock Northern Technologies Shares Are Diving Today

Northern Technologies International Corporation (NASDAQ:NTIC) shares are trading lower after the company reported the third quarter of fiscal 2024 results. Net sales fell 1.4% Y/Y to $20.7 million, missing the estimate of $23.0 million. ZERUST industrial net sales fell 4.4% Y/Y…

Money
Jul 11, 2024
HIV Medicine Maker Stock Soars

On Wednesday, Theratechnologies Inc (NASDAQ:THTX) reported second-quarter 2024 sales of $22.02 million, up 25.5% year over year, beating the consensus of $21.71 million. For the second quarter, net sales of EGRIFTA SV were $16.2 million, up 49.3% year over year, due to…

Money
Jul 10, 2024
Strategist Predicts ‘Landslide Defeat’ For Biden

David Axelrod, a former strategist for Barack Obama, predicted that President Joe Biden‘s campaign is in jeopardy following a poor debate performance against Donald Trump. What Happened: In an op-ed published on CNN on Monday, Axelrod highlighted an ABC interview…

Money
Jul 08, 2024
What’s Powering the Tesla Rally

Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in premarket trading on Monday and the upward move comes just ahead of the release of the company’s second-quarter deliveries report. The optimism is premised on faint hopes that Tesla can beat the…

Money
Jul 01, 2024